Recombinant Anti-CRLF2 Neutralizing Antibody (V3S-0622-YC120) (CAT#: V3S-0622-YC120)

Send Inquiry
  • fig1

Datasheet

MSDS

COA

Summary
Property
Applications
Protocols
Target

Summary

Description This product is a monoclonal antibody against thymic stromal lymphopoietin receptor. The antibody specifically recognizes and antagonizes human TSLPR, and can be useful for studying ameliorate diseases and disorder mediated by TSLP signaling.
Clonality Monoclonal
Host Species Mouse
Target Species Human
Isotype IgG1

Property

Expression Species HEK293F or CHO
Conjugation None
Purity >95%, determined by SDS-PAGE and SEC-HPLC
Endotoxin <1 EU/mg
Purification Protein G affinity purified
Sterility 0.2 μM filtered
Formulation PBS, pH 7.4
Preservation No preservatives
Stabilizer No stabilizers
Storage Store at 4°C within a week. For longer storage, aliquot and store at -20°C.

Applications

Application Antagonist; ELISA; FC; Inhib
Application Notes The antibody is recommended for detection of CRLF2 by Antagonist, ELISA, FC, Inhib assays.

Protocols

ELISA Enzyme-Linked Immunosorbent Assay Protocol
WB Western Blot Protocol
FC Flow Cytometry Protocol

Target

Target CRLF2
Alternative Name CRL2; TSLPR; CRLF2Y; cytokine receptor-like factor 2; IL-XR; TSLP receptor; cytokine receptor CRL2 precusor; thymic stromal lymphopoietin protein receptor; thymic stromal-derived lymphopoietin receptor
Gene ID 64109
UniProt Q9HC73
Related pathway STAT3, STAT5, and JAK2 pathways
For research use only, not directly for clinical use.
banner banner
© 2024 Creative Biolabs. All Rights Reserved.
antibody
Online Inquiry